Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
United Hospital
mi
from
Saint Paul, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Willmar Cancer Center at Rice Memorial Hospital
mi
from
Willmar, MN
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Willmar Cancer Center at Rice Memorial Hospital
mi
from
Willmar, MN
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Care, PC
mi
from
Saint Louis, MO
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Care, PC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Big Sky Oncology
mi
from
Great Falls, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Big Sky Oncology
mi
from
Great Falls, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Northern Montana Hospital
mi
from
Havre, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Northern Montana Hospital
mi
from
Havre, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
St. Peter's Hospital
mi
from
Helena, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Montana Cancer Center
mi
from
Missoula, MT
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of New Mexico Cancer Center - South
mi
from
Las Cruces, NM
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of New Mexico Cancer Center - South
mi
from
Las Cruces, NM
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Rutherford Hospital
mi
from
Rutherfordton, NC
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Rutherford Hospital
mi
from
Rutherfordton, NC
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Wood County Oncology Center
mi
from
Bowling Green, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Wood County Oncology Center
mi
from
Bowling Green, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Adena Regional Medical Center
mi
from
Chillicothe, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Adena Regional Medical Center
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
North Coast Cancer Care - Clyde
mi
from
Clyde, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
North Coast Cancer Care - Clyde
mi
from
Clyde, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Grant Medical Center Cancer Care
mi
from
Columbus, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Grant Medical Center Cancer Care
mi
from
Columbus, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Mount Carmel West Hospital
mi
from
Columbus, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mount Carmel West Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Grandview Hospital
mi
from
Dayton, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
mi
from
Delaware, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
mi
from
Delaware, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Hematology Oncology Center
mi
from
Elyria, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Hematology Oncology Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Community Cancer Center
mi
from
Elyria, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Community Cancer Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Middletown Regional Hospital
mi
from
Franklin, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Middletown Regional Hospital
mi
from
Franklin, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Wayne Hospital
mi
from
Greenville, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Wayne Hospital
mi
from
Greenville, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Fairfield Medical Center
mi
from
Lancaster, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Fairfield Medical Center
mi
from
Lancaster, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Lima Memorial Hospital
mi
from
Lima, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lima Memorial Hospital
mi
from
Lima, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Knox Community Hospital
mi
from
Mount Vernon, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Knox Community Hospital
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Fisher-Titus Medical Center
mi
from
Norwalk, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Fisher-Titus Medical Center
mi
from
Norwalk, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Toledo Clinic - Oregon
mi
from
Oregon, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Toledo Clinic - Oregon
mi
from
Oregon, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Community Hospital of Springfield and Clark County
mi
from
Springfield, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Flower Hospital Cancer Center
mi
from
Sylvania, OH
Click here to add this to my saved trials
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital of Tiffin
mi
from
Tiffin, OH
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital of Tiffin
mi
from
Tiffin, OH
Click here to add this to my saved trials